v1
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.
Identifier:nobleid.org/w1/20260515/4FFAFD07
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/4FFAFD07)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →